David B. Clayson
- Cancer Research top 1%
- Carcinogens and Genotoxicity Assessment 39
- Chemical Health and Safety top 2%
-
- Effects and risks of endocrine disrupting chemicals 9
- Aging top 5%
- Biochemistry top 2%
-
- Drug Transport and Resistance Mechanisms 8
-
- Bladder and Urothelial Cancer Treatments 8
-
- DNA Repair Mechanisms 7
- Genomics, phytochemicals, and oxidative stress 7
- Glutathione Transferases and Polymorphisms 7
-
- Animal testing and alternatives 5
- Co-authors
- Georgiana M. BonserF. IversonE.A. NeraE. LokJ. W. JullK. KarpinskiDavid B. LevineLeslie N. Pyrah
- Journals
- Cancer Letters (24 papers)British Journal of Cancer (17 papers)Mutation Research/Reviews in Genetic Toxicology (9 papers)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
David B. Clayson
124 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 144
- Cancer Research 1.2k
- Chemical Health and Safety 36
- Health, Toxicology and Mutagenesis 589
- Aging 49
- Biochemistry 176
Countries citing papers authored by David B. Clayson
This map shows the geographic impact of David B. Clayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Clayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Clayson more than expected).
Fields of papers citing papers by David B. Clayson
This network shows the impact of papers produced by David B. Clayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Clayson. The network helps show where David B. Clayson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David B. Clayson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 8 | |
| 2 | 1995 | 3 | |
| 3 | 1994 | 10 | |
| 4 | 1994 | 101 | |
| 5 | 1993 | 3 | |
| 6 | 1991 | 21 | |
| 7 | 1990 | 5 | |
| 8 | 1990 | 103 | |
| 9 | 1989 | 24 | |
| 10 | 1989 | 4 | |
| 11 | 1988 | 8 | |
| 12 | 1988 | 25 | |
| 13 | 1988 | 20 | |
| 14 | 1988 | 60 | |
| 15 | 1987 | 74 | |
| 16 | Inhibition of [3H]thymidine incorporation into DNA of rat esophageal epithelium and related tissues by carcinogenic N-nitroso compounds. | 1978 | 30 |
| 17 | The carcinogenic action of drugs. | 1976 | 4 |
| 18 | Nutrition and experimental carcinogenesis: a review. | 1975 | 53 |
| 19 | 1966 | 27 | |
| 20 | 1958 | 28 |
About David B. Clayson
David B. Clayson is a scholar working on Cancer Research, Aging, Biochemistry, Small Animals and Health, Toxicology and Mutagenesis, having authored 129 papers that have together received 3.1k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (39 papers), Effects and risks of endocrine disrupting chemicals (9 papers), Drug Transport and Resistance Mechanisms (8 papers), Bladder and Urothelial Cancer Treatments (8 papers), DNA Repair Mechanisms (7 papers), Genomics, phytochemicals, and oxidative stress (7 papers), Glutathione Transferases and Polymorphisms (7 papers) and Animal testing and alternatives (5 papers). The work is most often cited by research in Cancer Research (1.2k citations), Chemical Health and Safety (36 citations), Health, Toxicology and Mutagenesis (589 citations), Aging (49 citations) and Biochemistry (176 citations). David B. Clayson has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Georgiana M. Bonser, F. Iverson, E.A. Nera, E. Lok, J. W. Jull, K. Karpinski, David B. Levine, Leslie N. Pyrah, Rekha Mehta and Philippe Shubik. Their work appears in journals such as Cancer Letters, British Journal of Cancer, Mutation Research/Reviews in Genetic Toxicology, Food and Chemical Toxicology and Regulatory Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.